FindTrial
Sign In

Meta analysis of pulmonary artery sarcoma

Meta-analysis on diagnosis and treatment of pulmonary artery sarcoma - Meta-analysis on diagnosis and treatment of pulmonary artery sarcoma

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000053256
Enrollment
400
Registered
2024-01-01
Start date
2024-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary pulmonary artery sarcoma

Interventions

None listed

Sponsors

Yokohama Minami Kyosai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with pulmonary artery sarcoma

Exclusion criteria

Exclusion criteria: Patients with undiagnosed pulmonary artery sarcoma

Design outcomes

Primary

MeasureTime frame
Clinical features of primary pulmonary artery sarcoma—

Secondary

MeasureTime frame
Response rate and survival by treatment modality in pulmonary artery sarcoma—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa

Contacts

Public ContactFumiiro Kashizaki

Yokohama Minami Kyosai Hospital Department of Respiratory Medicine

f.kashizaki@gmail.com0457822101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026